Advertisement

Kardiale Erkrankungen

Zusammenfassung

In der postnatalen Phase ist der Kreislauf erheblichen Umstellungsvorgängen unterworfen. Dadurch werden z.B. einige in utero gut tolerierte angeborene Herzfehler unmittelbar post natum symptomatisch. Bedeutsam ist hierbei außerdem, daß das Herz des Neugeborenen schon physiologischerweise auf der Ebene eines hohen enddiastolischen Füllungsvolumens arbeitet [48]. Ferner ist die myokardiale Katecholaminkonzentration in den ersten Lebenstagen besonders niedrig [29] und die Utilisation langkettiger Fettsäuren gegenüber dem Erwachsenen eingeschränkt [19].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Achanti B, Yeh TF, Pildes RS (1986) Indomethacin therapy in infants with advanced postnatal age and patent ductus arteriosus. Clin Invest Med 9:250–253PubMedGoogle Scholar
  2. 2.
    Anthony CL, Arnon RG, Fitch CW (1979) Pediatric cardiology. Huber, Bern, p 423Google Scholar
  3. 3.
    Appleton RS, Graham TP Jr, Cotton RB, Moreau GA, Boucek RJ Jr (1988) Decreased early diastolic function after indomethacin administration in premature infants. J Pediatr 112:447–451PubMedCrossRefGoogle Scholar
  4. 4.
    Artman M, Graham TP Jr (1987) Guidelines for vasodilator therapy of congestive heart failure in infants and children. Am Heart J 113:994–1005PubMedCrossRefGoogle Scholar
  5. 5.
    Bada HS et al. (1989) Indomethacin therapy reduces the risks of severe intraventricular hemorrhage. J Pediatr 115:631PubMedCrossRefGoogle Scholar
  6. 6.
    Bancalari E, Sinclair JC (1992) Mechanical ventilation. In: Sinclair JC, Bracken MB (eds) Effective care of the newborn infant. Oxford Univ Press, Oxford, pp 214–215Google Scholar
  7. 7.
    Beekman RH, Rocchini AP, Dick IM, Crowley DC, Rosenthal A (1984) Vasodilator therapy in children: Acute and chronic effects in children with left ventricular dysfunction or mitral regurgitation. Pediatrics 73:43–51PubMedGoogle Scholar
  8. 8.
    Bloss RS, Turmen T, Beardmore HE, Aranda JV (1980) Tolazoline therapy for persistent pulmonary hypertension after congenital diaphragmatic hernia. J Pediatr 97:984–988PubMedCrossRefGoogle Scholar
  9. 9.
    Camm AJ, Garratt CJ (1991) Adenosin and supraventricular tachycardia. N Engl J Med 325:1621–1627PubMedCrossRefGoogle Scholar
  10. 10.
    Cooke RWI, Pickering D (1979) Poor response to oral indomethacin therapy for persistent ductus arteriosus in very low birthweight infants. Br Heart J 41:301–303PubMedCrossRefGoogle Scholar
  11. 11.
    Dooley KJ (1984) Management of the premature infant with a patent ductus arteriosus. Pediatr Clin North Am 31:1159–1174PubMedGoogle Scholar
  12. 12.
    Duara S, Gewitz MA, Fox WW (1984) Use of mechanical ventilation for clinical management of persistent pulmonary hypertension of the newborn. Clin Perinatol 11:641–652PubMedGoogle Scholar
  13. 13.
    Esscher E, Michaelsson M, Smedy B (1975) Cardiovascular malformation in infant death. Br Heart J 37:824–829PubMedCrossRefGoogle Scholar
  14. 14.
    Fleming WH, Sarafian LB, Kobayashi RH (1984) Prostaglandin E1 therapy; is it associated with a higher incidence of wound infection in the cyanotic neonate? Chest 85:241–243PubMedCrossRefGoogle Scholar
  15. 15.
    Freedom RM, Smallhorn JF, Trusler JA (1992) Transposition of the great arteries. In: Freedom RM, Benson LN, Smallhorn JF (eds) Neonatal heart disease. Springer, Berlin Heidelberg New York Tokyo, pp 179–212Google Scholar
  16. 16.
    Frostell CG, Fratacci MD, Wain JC, Jones R, Zapol WM (1991) Inhaled nitric oxide: A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83:2083–2047CrossRefGoogle Scholar
  17. 17.
    Garson A Jr (1984) Arrhythmias in pediatric patients. Med Clin North Am 68:1187–1195Google Scholar
  18. 18.
    Gillette PC, Ross BA, Fyfe DA, Dudeles D, Zeigler V, Harold M (1988) Neonatal cardiac arrhythmias and their potential role in sudden infant death syndrome. Clin Perinat 15:699–712Google Scholar
  19. 19.
    Gingell RL (1992) Developmental biology of mammalian myocardium. In: Freedom RM, Benson LN, Smallhorn JF (eds) Neonatal heart disease. Springer, Berlin Heidelberg New York Tokyo, pp 35–44Google Scholar
  20. 20.
    Green TP, Thompson TR, Johnson DE, Lock JE (1983) Furosemide promotes patent ductus arteriosus in premature infants with the respiratory distress syndrome. N Engl J Med 308:743–748PubMedCrossRefGoogle Scholar
  21. 21.
    Hagel KJ, Rautenburg HW (1987) Ballondilatation bei angeborenen Pulmonalstenosen im Kindesalter. Herz/Kreisl 19:343–347Google Scholar
  22. 22.
    Hammerman C, Aramburo MJ (1990) Prolonged indomethacin therapy for the prevention of recurrence of patent ductus arteriosus. J Pediatr 117:771–776PubMedCrossRefGoogle Scholar
  23. 23.
    Hammerman C, Yousefzadeh D, Choi J-H, Bui K-C (1989) Persistent pulmonary hypertension of the newborn. Clin Perinatol 16:137–156PubMedGoogle Scholar
  24. 24.
    Haworth SG, Sauer U, Bühlmeyer K(1980) Effect of prostaglandin E1 on pulmonary circulation in pulmonary atresia. A quantitative morphometric study. Br Heart J 43:306–314PubMedCrossRefGoogle Scholar
  25. 25.
    Izukawa T, Lightfoot NE (1992) Trends in neonatal congenital heart disease. The Toronto experience. In: Freedom RM, Benson LN, Smallhorn JF (eds) Neonatal heart disease. Springer, Berlin Heidelberg New York Tokyo, pp 31–34CrossRefGoogle Scholar
  26. 26.
    Kelley JG (1986) Digoxin receptors in the neonate. In: Doyle EF, Engle MA, Gersony WM, Rashkind WJ, Talner NS (eds) Pediatric cardiology. Springer, Berlin Heidelberg New York Tokyo, pp 1233 ffCrossRefGoogle Scholar
  27. 27.
    Kidd BSL (1978) Complete transposition of the great arteries. In: Keith JD, Rowe RJ, Vlad P (eds) Heart disease in infancy and childhood, 3rd edn. Macmillan, New York, p 628Google Scholar
  28. 28.
    Kirk CR, Gibbs JL, Thomas R, Radley-Smith R, Quershi SA (1987) Cardiovascular collapse after Verapamil in supraventricular tachycardia. Arch Dis Child 62:1265–1266PubMedCrossRefGoogle Scholar
  29. 29.
    Klopfenstein HS, Rudolph AM (1978) Postnatal changes in the circulation and response to volume overload in sheep. Circ Res 42:839–845PubMedCrossRefGoogle Scholar
  30. 30.
    Kramer HH, Krian A, Rammos S et al. (1987) Anatomische Korrektur der D-TGA beim Neugeborenen. Prä- und postoperativer Verlauf und hämodynamische Ergebnisse. Herz/Kreisl 19:58Google Scholar
  31. 31.
    Krogmann ON, Rammos S, Heusch A, Bourgeois, M (1992) Rhythmusstörungen im Kindesalter. Monatsschr Kinderheilkd 140:F83–F97Google Scholar
  32. 32.
    Kühl G, Wille L, Bolkenius M, Seiberth HW (1985) Intestinal perforation associated with indomethacin treatment in premature infants. Eur J Pediatr 143:213–216PubMedCrossRefGoogle Scholar
  33. 33.
    Lewis AB, Freed MD, Heymann MA, Roehl SL, Kensey RC (1981) Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation 64:893–898PubMedCrossRefGoogle Scholar
  34. 34.
    Lindner KH, Ahnefeld FW (1987) Soforttherapie bei Kreislaufstillstand. Krankenhausarzt 60:232–237Google Scholar
  35. 35.
    Long WA (1990) Persistent pulmonary hypertension of the newborn syndrome (PPHNS). In: Long WA (ed) Fetal and neonatal cardiology. Saunders, Philadelphia, pp 627–655Google Scholar
  36. 36.
    Netz H (1982) Kritische angeborene Herzfehler: klinische Zeichen und Diagnostik. Diagn Intensivmed 7:17–23Google Scholar
  37. 37.
    Philips JB III (1990) Treatment of PPHNS. In: Long WA (ed) Fetal and neonatal cardiology. Saunders, Philadelphia, pp 691–701Google Scholar
  38. 38.
    Quinton DN, O’Byrne G, Aitkenhead AR (1987) Comparison of endotracheal and peripheral intravenous adrenalin in cardiac arrest. Lancet I: 828–829CrossRefGoogle Scholar
  39. 39.
    Roberts JD, Polaner DM, Lang P, Zapol WM (1992) Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340:818–819PubMedCrossRefGoogle Scholar
  40. 40.
    Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328:399–405PubMedCrossRefGoogle Scholar
  41. 41.
    Samánek M, Goetzová J, Benesova D (1986) Causes of death in neonates with a heart malformation. Int J Cardio111:63–74Google Scholar
  42. 42.
    Schneider M, Kampmann C, Schulze-Neick I, Hausdorf G, Lange PE (1993) Antegrade Ballonvalvuloplastie einer kritischen Aortenstenose bei einem 1820 g schweren Säugling. Z Kardiol 82:131–134PubMedGoogle Scholar
  43. 43.
    Schröder R, Ramdohr B, Hüttemann U, Schüren KP (1972) Direkte positiv-inotrope Herzwirkung von Aldactone. Dtsch Med Wochenschr 97:1535–1538PubMedCrossRefGoogle Scholar
  44. 44.
    Schumacher G, Bühlmeyer K (1980) Diagnostik angeborener Herzfehler. Straube, ErlangenGoogle Scholar
  45. 45.
    Stahlman MT (1987) Persistent pulmonary hypertension of the newborn. In: Avery GB (ed) Neonatology, 3rd edn. Lippincott, Philadelphia, pp 422–424Google Scholar
  46. 46.
    Steinhoff HH (1987) Einfluß von Dopamin und Dobutamin auf die Nierenfunktion, Krankenhausarzt 60:362–365Google Scholar
  47. 47.
    Stoermer J, Hentrich F, Galal O, Trede S (1984) Risiko der Herzkatheterisierung und Angiokardiographie im Säuglings- und Kindesalter. Klin Pädiatr 196:191–194PubMedCrossRefGoogle Scholar
  48. 48.
    Talner NS (1986) Some new approaches to the management of congestive heart failure. In: Doyle EF, Engle MA, Gersony WM, Rashkind WJ, Talner NS (eds) Pediatric cardiology. Springer, Berlin Heidelberg New York Tokyo, pp 1227 ff.CrossRefGoogle Scholar
  49. 49.
    Thanapoulos BD, Andreon A, Frunos C (1987) Prostaglandin E2 administration in infants with ductus-dependent cyanotic heart disease. J Pediatr 146:279–282Google Scholar
  50. 50.
    Toomasian JM, Snedecor SM, Cornell RG, Cilley RE, Bartlett RH (1988) National experience with extracorporal membrane oxygenation for newborn respiratory failure. Am Soc Artif Intern Organ Trans 34:140–147CrossRefGoogle Scholar
  51. 51.
    Walsh-Sukys M (1993) Persistent pulmonary hypertension of the newborn: The black box revisited. Clin Perinat 20:127–143Google Scholar
  52. 52.
    Wennberg RP, Rasmussen LF, Ahlfors CI (1977) Displacement of bilirubin from human albumin by the diuretics. J Pediatr 90:647–650PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • G. Bein

There are no affiliations available

Personalised recommendations